rs141855950
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001040616.3(LINS1):āc.1813A>Gā(p.Met605Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00342 in 1,613,844 control chromosomes in the GnomAD database, including 15 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Consequence
NM_001040616.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LINS1 | NM_001040616.3 | c.1813A>G | p.Met605Val | missense_variant | 7/7 | ENST00000314742.13 | NP_001035706.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LINS1 | ENST00000314742.13 | c.1813A>G | p.Met605Val | missense_variant | 7/7 | 5 | NM_001040616.3 | ENSP00000318423.8 | ||
LINS1 | ENST00000559169.1 | n.2088A>G | non_coding_transcript_exon_variant | 2/2 | 2 | |||||
LINS1 | ENST00000560783.1 | n.190+3952A>G | intron_variant | 5 | ENSP00000474128.1 |
Frequencies
GnomAD3 genomes AF: 0.00249 AC: 379AN: 152116Hom.: 2 Cov.: 32
GnomAD3 exomes AF: 0.00273 AC: 686AN: 251096Hom.: 3 AF XY: 0.00299 AC XY: 406AN XY: 135712
GnomAD4 exome AF: 0.00352 AC: 5142AN: 1461610Hom.: 13 Cov.: 34 AF XY: 0.00351 AC XY: 2550AN XY: 727086
GnomAD4 genome AF: 0.00249 AC: 379AN: 152234Hom.: 2 Cov.: 32 AF XY: 0.00203 AC XY: 151AN XY: 74424
ClinVar
Submissions by phenotype
not provided Benign:4
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Mar 01, 2024 | LINS1: BP4, BS2 - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics | Nov 07, 2016 | - - |
not specified Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Jan 19, 2017 | - - |
Benign, criteria provided, single submitter | clinical testing | Genomic Diagnostic Laboratory, Division of Genomic Diagnostics, Children's Hospital of Philadelphia | Jun 17, 2015 | - - |
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 12, 2018 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at